FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

421783007: Iotroxate meglumine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2006. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2617552017 Meglumine iotroxate en Synonym Active Entire term case insensitive SNOMED CT core module
3753739010 Iotroxate meglumine (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3753740012 Meglumine iotroxinate en Synonym Active Entire term case insensitive SNOMED CT core module
3753741011 Iotroxate meglumine en Synonym Active Entire term case insensitive SNOMED CT core module
3753742016 Iotroxic acid meglumine en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Iotroxate meglumine Is a Radiopaque agent false Inferred relationship Existential restriction modifier
Iotroxate meglumine Is a Contrast media false Inferred relationship Existential restriction modifier
Iotroxate meglumine Is modification of Iotroxic acid true Inferred relationship Existential restriction modifier
Iotroxate meglumine Is a Iodinated contrast media true Inferred relationship Existential restriction modifier
Iotroxate meglumine Is a Benzoate derivative true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing meglumine iotroxate Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier 1
Product containing meglumine iotroxate in parenteral dose form (medicinal product form) Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier 1
Product containing only meglumine iotroxate (medicinal product) Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier 1
Product containing only meglumine iotroxate in parenteral dose form (medicinal product form) Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier 1
Product containing precisely iodine (as iotroxate meglumine) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Iotroxate meglumine Inferred relationship Existential restriction modifier 1
Meglumine iotroxate 105mg/ml (Iodine 50mg/ml) solution for injection 100ml bottles Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier
Meglumine iotroxate 105mg/ml (Iodine 50mg/ml) solution for injection 100ml bottles 10 bottle Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) 10 bottle Has active ingredient False Iotroxate meglumine Inferred relationship Existential restriction modifier
Meglumine iotroxate 105mg/ml (Iodine 50mg/ml) solution for injection 100ml bottles Has specific active ingredient True Iotroxate meglumine Inferred relationship Existential restriction modifier
Meglumine iotroxate 105mg/ml (Iodine 50mg/ml) solution for injection 100ml bottles 10 bottle Has specific active ingredient True Iotroxate meglumine Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) 10 bottle Has specific active ingredient True Iotroxate meglumine Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has specific active ingredient True Iotroxate meglumine Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has active ingredient True Iotroxate meglumine Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start